SELANK/SEMAX

SELANK + SEMAX — 10MG / 10MG

Dual Regulatory Peptide Research Blend

A combined research preparation containing 10MG Selank + 10MG Semax, two synthetic regulatory heptapeptides widely investigated in neurochemical and molecular research.

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) has been studied for its interactions with GABAergic signaling and peptide-regulating pathways. Experimental research has examined its effects on GABA receptor modulation and enkephalin-degrading enzymes.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic ACTH(4-7)-derived peptide investigated across neurochemical, neurotrophic, oxidative-stress, and neuroprotective research models. Published studies have examined Semax in relation to neurotrophin signaling, monoaminergic pathways, gene expression, and cellular responses to neurological stress.

RESEARCH CONTENT

- Selank: 10MG

- Semax: 10MG

- Total Peptide Content: 20MG

RESEARCH AREAS

- GABAergic signaling

- Neurotransmitter pathway research

- Neurotrophic signaling

- Neuroplasticity mechanisms

- Cellular stress-response pathways

- Cognitive and behavioral research models

- Peptide/enzyme interactions

For Research Use Only. Not intended for human consumption, diagnostic use, therapeutic use, or veterinary use.